Modern Diagnostic & Research Centre Ltd IPO

Experienced Promoter and Management Team.

Comprehensive diagnostics provider delivering all-in-one solution at cost-effective prices.

Focus on quality and customer service.

Centralized information technology platform.

Any interruptions at its laboratories and diagnostic centres may affect the companys ability to process diagnostic tests, which in turn may adversely affect its business, results of operations and financial condition.

The companys business and prospects may be adversely affected if the company is unable to maintain and grow its brand name and brand image.

Majority of the companys operations are concentrated in state of Haryana and any adverse developments affecting Haryana could have an adverse effect on its business, results of operations and financial condition.

The company has certain outstanding litigation against us, an adverse outcome of which may adversely affect its business, reputation and results of operations.

There may be significant dependence on key diagnostic equipment and core technology infrastructure, the failures of which could result in serious service disruptions.

The companys heavy reliance on pathology services as the primary revenue driver presents significant risks that could negatively impact its operations, financial performance, and long-term growth prospects.

Failures to attract and retain skilled healthcare professionals and experienced technical staff may lead to compromised diagnostic service quality and negatively impact patient care delivery.

The company has experienced negative cash flows in the past. Any such negative cash flows in the future could affect its business,results of operations and prospects.

Our Restated Financial Statements are prepared and signed by the Peer Review Auditor who is not Statutory Auditor of our Company as required under the provisions of ICDR.

Our Company has incurred losses in last two financial years as per Restated Financial Statements, which may impact our financial performance.